{"id":2755,"date":"2024-06-21T16:40:18","date_gmt":"2024-06-21T14:40:18","guid":{"rendered":"https:\/\/avmc.cz\/out-licensing-cz\/"},"modified":"2024-08-07T19:36:33","modified_gmt":"2024-08-07T17:36:33","slug":"out-licensing","status":"publish","type":"page","link":"https:\/\/avmc.cz\/en\/out-licensing\/","title":{"rendered":"Out-licensing"},"content":{"rendered":"\n
\n

Out-licensing<\/h1>\n\n\n\n

We develop niche Rx molecules addressing low market availability, difficult licensing or market shortages.<\/p>\n<\/div>\n\n\n\n

\n
\n
\n
\n

Rx molecules<\/h2>\n\n\n\n

All products are developed and manufactured in the European Union, following EU guidelines. Each molecule is designed for stability in climatic zones II, IVa, and IVb.<\/p>\n\n\n\n

Stability II, IVa, IVb<\/h2>\n\n\n\n

Stability testing ensures pharmaceuticals remain safe, effective, and meet regulatory standards across different environmental conditions that may be encountered during distribution and storage.<\/p>\n\n\n\n

Partner with us<\/h2>\n\n\n\n

We are proud to announce the successful launch of our niche RX molecule business in multiple EU countries, advancing healthcare solutions. We invite prospective partners to join us in bringing cutting-edge solutions to patients around the world.<\/p>\n\n\n\n

\n
Contact us<\/a><\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/figure>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n

Featured products<\/h2>\n
\n
\n \n \t\n\t\t\n\t\t\t\t\t\t\t\"Oxacillin\n\t\t\t\n <\/a>\n
Oxacillin AVMC 1000 mg<\/figcaption>\n<\/figure> <\/figure>\n<\/div>\n\n\n

Contact us for more information<\/h2>\n\n\n
\n In & Out-licensing + Contact<\/legend> \n
\n